QurieGen
6 known investors
Find your way into QurieGen
QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
Investors · 6
BSV VenturesVilnius · $5K – $430K
Draper AssociatesSan Mateo · $500K – $5M
Lighthouse Venturesreported · 2 sourcesPrague · $220K – $1.1M
Tensor Venturesreported · 2 sourcesSenningerberg
Also in the syndicate · 2
22 Hor InvestMoondust Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedApr 2025 · 3 sources
Tensor Ventures (lead), 22 Hor Invest, BSV Ventures, Draper Associates, Lighthouse Ventures, Moondust Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapPixelgen3 shared keywordsPixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
Vizgen3 shared keywordsVizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.
Companies competing with QurieGen for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does QurieGen do?
- QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
- Who are QurieGen's investors?
- QurieGen's investors include BSV Ventures, Draper Associates, Lighthouse Ventures, Tensor Ventures.





